Literature DB >> 3142055

Economic impact of total hip arthroplasty.

F Cushner1, R J Friedman.   

Abstract

Since the first successful total hip arthroplasty (THA) 28 years ago, this procedure has enabled millions of people to walk without pain. The overall incidence of THA has more than tripled in the last five years, now exceeding 196,000 cases annually. The direct and indirect costs of THA exceed $4.9 billion annually. Though the economic benefits of THA offset this figure by $1.85 billion, the costs nevertheless have a significant impact on the health care system. Although THA is expensive, the excellent long-term results make it well worth the expense.

Entities:  

Mesh:

Year:  1988        PMID: 3142055     DOI: 10.1097/00007611-198811000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.

Authors:  C J Dunn; K L Goa
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

2.  Prevalence of total hip replacement: how much demand has been met?

Authors:  M H Williams; J N Newton; S J Frankel; F Braddon; E Barclay; J A Gray
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

3.  Total hip arthroplasty: use and select complications in the US Medicare population.

Authors:  J A Baron; J Barrett; J N Katz; M H Liang
Journal:  Am J Public Health       Date:  1996-01       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.